Getinge Ab Class B · OMXSTO:GETI_B
Getinge Ab Class B — Investor Presentation (2006)
28 slides from Getinge Ab Class B's investor presentation, 2006
Slide 1: Getinge Group
Getinge Group xe GETINGE
Slide 2: Shaping Health Care of tomorrow
Shaping Health Care of tomorrow Net Sales 10.9 billion SEK INFECTION CONTROL EXTENDED CARE MEDICAL SYSTEMS Production units 10 Production units 5 Production units 5 Sales companies 25 Sales companies 24 Sales companies 23
Slide 3: Shaping Health Care of tomorrow
Shaping Health Care of tomorrow Customer Segment Business Area Geographical regions 70% 25% 32% 29% 55% 5% 8% 43% 11% 22% North America 29% Hospital 70% Infection Control 32% W Europe 55% Longterm Care 22% Extended Care 25% Asia Pacific 11% Life Science 8% Medical Systems 43% RoW 5%
Slide 4: Infection Control - Fact sheet 2004 numbers
Infection Control- Fact sheet 2004 numbers Revenues 3,524 MSEK EBITA margin 15.2 % Customers Product Lines Geographical 60% 62% 45% 36% 10% 7% 38% 12% 30% W Europe 45% Hospital Sterilization 62% US&Canada 36% Elderly Care Asia&Australia 12% Life Science Disinfection 38% RoW 7%
Slide 5: Extended Care - Fact sheet 2004 Numbers
Extended Care – Fact sheet 2004 Numbers Revenues 2,701 MSEK EBITA margin 18.9 % Customers Product Lines Geographical 65% 37% 30% 55% 46% 1% 15% 17% 3% 31% W Europe 65% Hospital 30% Patient Handling 37% US&Canada 31% Elderly Care 55% Hygiene Systems 46% Asia&Australia 3% Home Care 15% Wound Care 17%
Slide 6: Medical Systems - Fact sheet 2004 Numbers
Medical Systems – Fact sheet 2004 Numbers Revenues 4,620 MSEK EBITA margin 15.4 % Customers Product Lines * Geographical 15% 58% 100% 36% 6% 16% 20% 6% 16% 27% Tables 36% W Europe 58% Lights 15% US&Canada 20% Pendants 6% Asia&Australia 16% Cardio-Pulmonary 16% RoW 6% Hospital Critical Care 27%
Slide 7: Getinge Group Development
Getinge Group Development xe GETINGE
Slide 8: Getinge has gained a competitive position in health care that will be further strengthened
Getinge has gained a competitive position in health care that will be further strengthened by current trends Shift in power Increased balance co-payment Our Financial customers in deficits and Increased use of Technology Cost health care unaffordable competition breakthrough containment respond to h
Slide 9: Our customers in the healthcare industry respond to the changes by...
Our customers in the healthcare industry respond toFinancial Targets the changes by… Health care policy makers will increasingly look for privatisation and market testing as tools to achieve cost efficiency Activity based reimbursements continue to drive process efficiency Focus on core compet
Slide 10: Positive Outcomes
Positive Outcomes A competent solution provider in well defined niches of the health care industry – offering solutions that enhance customers’ productivity over time
Slide 11: Strategic Cornerstones
Strategic Cornerstones Global leadership
Slide 12: Global leadership
Global leadership We strive to be a global No 1 or No 2 in the product areas focused. Market leadership will help us attain cost leadership through scale Infection Control Sterilization No 1 Disinfection No 1 Extended Care Patient Handling No 1 Hygiene Systems No 1 Wound Care No 4 Medical Systems Su
Slide 13: Strategic Cornerstones
Strategic Cornerstones Global leadership Innovative solutions
Slide 14: Innovative Solutions
Innovative Solutions We strive to combine the strength of our leading product positions and the depth of our know-how to offer innovative solutions that lead to process improvements for our customers Sterilization Integrated Disinfection Infection Control Load Handling solutions IT-systems Integrate
Slide 15: Competitive position
Competitive position Our competitive position will be based on cost leadership and innovations in solutions System Getinge Innovations Products Cost Innovation Leadership
Slide 16: Strategic Cornerstones
Strategic Cornerstones Global leadership Innovative solutions Direct Sales and Service approach
Slide 17: Direct Sales & Service Approach
Direct Sales & Service Approach A direct approach to our customers is crucial to our succcess Getinge will strive to establish own distribution companies whenever justifiable Solution provider Transfer and exchange of know-how Control all parameters that define customer satisfaction Control
Slide 18: Financial Targets
Financial Targets Growth is the backbone of our development to remain a dynamic and attractive company and to fund our targeted expansion Growth in pretax earnings > 15% p a Cash-flow to sustain external growth rate > 10% p a
Slide 19: Results 1993 - 2004
Results 1993 - 2004 12000 1400 10000 1200 8000 1000 800 6000 600 4000 400 2000 200 CAGR 23% 0 0 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 Invoiced sales *) Profit before tax
Slide 20: Financial Targets by Business Area
Financial Targets by Business Area Target A2004 Organic growth 4–5% EBITA margin ~ 16 % 15.2 % Target A2004 Organic growth ~7% EBITA margin ~ 19 % 18.9 % Target A2004 Organic growth ~5% EBITA margin ~ 17 % 15.4 % GROUP Target A2004 Organic growth ~5%+ EBITA margin ~ 17 % + 16.1 %
Slide 21: 2004 Financials
2004 Financials xe GETINGE
Slide 22: Getinge AB - Financials (MSEK)
Getinge AB - Financials (MSEK) 2004 2003 Change 2004 2003 Change Q4 Q4 12 Mon 12 Mon Orders received 2,981 2,675 11% 10,812 9,154 18% Net sales 3,477 2,929 19% 10,889 9,160 19% EBITA 682 544 25% 1,757 1,449 21% EBITA % 19.6% 18.6% 16.1% 15.8% EBIT 621 477 30% 1,505 1,257 20% EBIT % 17.9% 16.3% 13.8%
Slide 23: Getinge AB - Key figures (MSEK)
Getinge AB - Key figures (MSEK) 2004 2003 2004 2003 Q4 Q4 12 Mon 12 Mon Operating Cash Flow, MSEK 584 556 1,878 1,980 Net debt, MSEK 4,705 4,852 Equity / Assets ratio, % 33.1% 29.3% Net debt / Equity ratio, multiple 1.18 1.37 Interest cover, multiple 7.1 7.3
Slide 24: Strategy for Growth
Strategy for Growth The Getinge group will reach its growth targets by: Development of existing positions Organic growth Bolt-on acquisitions Acquisitions of new globally leading product lines that will strengthen our position as an innovative provider of solutions
Slide 25: Strategy for growth 2004 - 2007 Infection Control
Strategy for growth 2004 – 2007 Infection Control Principally organic growth supplemented by bolt-on acquisitions to reach new geographical territories, add new technologies in existing product lines Strengthen solution provider capabilities Focused approach towards the global Life Science indus
Slide 26: Strategy for growth 2004 - 2007 Extended Care
Strategy for growth 2004 – 2007 Extended Care Principally organic growth on existing markets supplemented by bolt-on acquisitions to add new technologies in existing product lines Total bed-side management in elderly care Enter the hospital market / bariatric care Improved supply chain for inc
Slide 27: Strategy for growth 2004 - 2007 Medical Systems
Strategy for growth 2004 – 2007 Medical Systems Organic growth on existing markets and existing product lines Acquisitions of new globally leading product lines that will strengthen our position as an innovative solution provider with special emphasis on critical care and cardiac surgery Position
Slide 28: Solid base - bright future
Solid base - bright future Getinge has gained a competitive position in its market that will be further strengthened by current trends Infection Control is positioned to achieve solid organic growth over coming years. Efforts and activities to improve the production structure and logistics will stre